The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis
Open accessAbstract
The change of brain lesion load, measured on T 2‐weighted magnetic resonance imaging (MRI) using computer‐assisted techniques, is a widely used secondary endpoint for phase III clinical trials in multiple sclerosis (MS). Collections, transfer, and analysis of the electronic data across multiple centers have all proved challenging and give rise to potential errors. However, many new acquisition schemes and postprocessing techniques have been developed; these may reduce scan times and result in better lesion conspicuity or lessen the human interaction needed for data analysis. This review considers many aspects of the use of MRI in clinical trials for MS and provides international consensus guidelines, derived from a task force of the European Magnetic Resonance Networks in Multiple Sclerosis (MAGNIMS) together with a group of North American experts. The main points considered are the organization of correctly powered trials and selection of participating sites; the appropriate choice of pulse sequences and image acquisition protocol given the current state of technology; quality assurance for data acquisition and analysis; accuracy and reproducibility of lesion load assessments; and the potential for the application of quantitative methods to other MRI‐derived measures of disease burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Miller, D. H., Albert, P. S., Barkhof, F., Francis, G., Frank, J. A., Hodgkinson, S., Lublin, F. D., Paty, D. W., Reingold, S. C., & Simon, J. (1996) · Annals of Neurology · doi:10.1002/ana.410390104 · Cited by 444
Self-citation
Cited by
The peripheral benzodiazepine binding site in the brain in multiple sclerosis
Banati, R. B., Newcombe, J., Gunn, R. N., Cagnin, A., Turkheimer, F., Heppner, F., Price, G., Wegner, F., Giovannoni, G., Miller, D. H., et al. (2000) · Brain · doi:10.1093/brain/123.11.2321 · Cited by 661
Self-citationComi, G., Filippi, M., Wolinsky, J. S., & European/Canadian Glatiramer Acetate Study Group (2001) · Annals of Neurology · doi:10.1002/ana.64 · Cited by 650
Self-citationCT and MRI Rating of White Matter Lesions
Fazekas, F., Barkhof, F., Wahlund, L. O., Pantoni, L., Erkinjuntti, T., Scheltens, P., & Schmidt, R. (2002) · Cerebrovascular Diseases · doi:10.1159/000049147 · Cited by 337
Self-citationReddy, H., Narayanan, S., Arnoutelis, R., Jenkinson, M., Antel, J., Matthews, P. M., & Arnold, D. L. (2000) · Brain · doi:10.1093/brain/123.11.2314 · Cited by 312
Cercignani, M. (2001) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.3.311 · Cited by 291
Metadata
- Authors
- Filippi, M., Horsfield, M. A., Adèr, H. J., Barkhof, F., Bruzzi, P., Evans, A., Frank, J. A., Grossman, R. I., McFarland, H. F., Molyneux, P., Paty, D. W., Simon, J., Tofts, P. S., Wolinsky, J. S., & Miller, D. H.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1998-04
- Volume
- 43
- Issue
- 4
- Pages
- 499-506
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2026464828
- Cited by
- 172
- References
- 2
- FWCI
- 12.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. https://app.cochat.ai/papers/10.1002/ana.410430414
- The paper
- Filippi, M., Horsfield, M. A., Adèr, H. J., Barkhof, F., Bruzzi, P., Evans, A., Frank, J. A., Grossman, R. I., McFarland, H. F., Molyneux, P., Paty, D. W., Simon, J., Tofts, P. S., Wolinsky, J. S., & Miller, D. H. (1998). Guidelines for using quantitative measures of brain magnetic resonance imaging abnormalities in monitoring the treatment of multiple sclerosis. Annals of Neurology. https://doi.org/10.1002/ana.410430414
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.